Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa.
Raugi DN, Ba S, Cisse O, Diallo K, Tamba IT, Ndour C, Badiane NMD, Fortes L, Diallo MB, Faye D, Smith RA, Sall F, Toure M, Sall EI, Diallo Agne H, Faye K, Diatta JP, Sy MP, Chang M, Diaw B, Sambou J, Bakhoum R, Sy MD, Niang A, Malomar JJ, Coombs RW, Hawes SE, Ndoye I, Kiviat NB, Sow PS, Seydi M, Gottlieb GS; University of Washington–Senegal HIV-2 Study Group.
Raugi DN, et al. Among authors: diallo k, diallo mb, diallo agne h.
Clin Infect Dis. 2021 Feb 1;72(3):369-378. doi: 10.1093/cid/ciaa277.
Clin Infect Dis. 2021.
PMID: 33527119
Free PMC article.